ABC | Volume 111, Nº2, Agosto 2018

Diretrizes 3ª Diretriz Brasileira de Transplante Cardíaco Arq Bras Cardiol. 2018; 111(2):230-289 261. Garcia RL, Matos BM, Féres O, Rocha JJ. Surgical treatment of Chagas megacolon. Critical analysis of outcome in operative methods. Acta Cir Bras. 2008;23 Suppl 1:83-92. PMID: 18516454. 262. Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al; International Society of Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33(10):996-1008. doi: 10.1016/j.healun.2014.08.003. 263. Bestetti RB, Souza TR, Lima MF, Theodoropoulos TA, Cordeiro JA, Burdmann EA. Effects of a mycophenolate mofetil- based immunosuppressive regimen in Chagas` heart transplant recipients. Transplantation. 2007;84(3):441-2. doi: 10.1097/01. tp.0000277526.68754.02. 264. Bacal F, Silva CP, Bocchi EA, Pires PV, Moreira LF, Issa VS, et al. Mycophenolate mofetil increased Chagas’ disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Transplant. 2005;5(8):2017-21. doi: 10.1111/j.1600- 6143.2005.00975.x. 265. Fiorelli AI, Santos RH, Oliveira JL Jr, Lourenço-FilhoDD, Dias RR, Oliveira AS, et al. Heart transplantation in 107 cases of Chagas’ disease. Transplant Proc. 2011;43(1):220-4. doi: 10.1016/j.transproceed.2010.12.046. 266. Godoy HL, Guerra CM, Viegas RF, Dinis RZ, Branco JN, Neto VA, et al. Infections in heart transplant recipients in Brazil: the challenge of Chagas’ disease. J Heart Lung Transplant. 2010;29(3):286-90. doi: 10.1016/j. healun.2009.08.006. 267. Bern C. Antitrypanosomal therapy for chronic Chagas’ disease. N Engl J Med. 2011;364(26):2527-34. doi: 10.1056/NEJMct1014204. 268. Maldonado C, Albano S, Vettorazzi L, SalomoneO, Zlocowski JC, Abiega C, et al. Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation. J Heart Lung Transplant. 2004;23(12):1345-8. doi: 10.1016/j.healun.2003.09.027. 269. Diez M, Favaloro L, Bertolotti A, Burgos JM, Vigliano C, Lastra MP, et al. Usefulness of PCR strategies for early diagnosis of Chagas’ disease reactivation and treatment follow-up in heart transplantation. Am J Transplant. 2007;7(6):1633-40. doi: 10.1111/j.1600- 6143.2007.01820.x. 270. Bocchi EA, Fiorelli A; First guideline group for heart transplantation of the Brazilian Society of Cardiology. The Brazilian experience with heart transplantation: a multicenter report. J Heart Lung Transplant. 2001;20(6):637-45. PMID: 11404169. 271. de Souza MM, Franco M, Almeida DR, Diniz RV, Mortara RA, da Silva S, et al. Comparative histopathology of endomyocardial biopsies in chagasic and nonchagasic heart transplant recipients. J Heart Lung Transplant. 2001;20(5):534-43. doi: 11343980. 272. Qvarnstrom Y, Schijman AG, Veron V, Aznar C, Steurer F, da Silva AJ. Sensitive and specific detection of Trypanosoma cruzi DNA in clinical specimens using a multitarget real-time PCR approach. PLoS Negl Trop Dis. 2012;6(7):e1689. doi: 10.1371/journal.pntd.0001689. 273. Dias JCP, Ramos Jr. NA, Gontigo ED, Luquetti A, Shikamai-Yasuda MA, Coura JR, et al. II Consenso Brasileiro em Doença de Chagas. Epidemiol Serv Saúde, Brasília; 2016;25(num esp):7-86. doi: 10.5123/S1679- 49742016000500002. 274. Almeida DR, Carvalho AC, Branco JN, Pereira AP, Correa L, Vianna PV, et al. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment. J Heart Lung Transplant. 1996;15(10):988-92. PMID: 8913915. 289